Biodesix Inc.

BDSX | NASDAQ

Price Alert Chart Builder DCF Calculator

$28.74

+$0.31 (+1.09%)

Sep 22, 2026, 2:22 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-35.27M	-42.93M	-52.15M	-65.45M	-43.16M	-31.35M
Depreciation & Amortization	5.6M	5.46M	5.51M	5.84M	3.18M	2.9M
Stock-Based Compensation	4.14M	6.64M	5.37M	5.96M	4.94M	3.71M
Other Working Capital	865K	-21.52M	15.34M	-2.98M	-6.86M	5.51M
Other Non-Cash Items	1.92M	3.86M	7.09M	13.01M	4.33M	6.58M
Deferred Income Tax	n/a	n/a	n/a	n/a	-2.11M	1.6M
Change in Working Capital	334K	-21.67M	11.3M	-4.34M	4.59M	-4.8M
Operating Cash Flow	-23.27M	-48.65M	-22.87M	-44.97M	-28.22M	-21.37M
Capital Expenditures	-403K	-3.23M	-23.06M	-3.53M	-2.55M	-2.18M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	-750K
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-144K	-210K	-143K	-236K	-306K	n/a
Investing Cash Flow	-403K	-3.44M	-23.06M	-3.53M	-2.55M	-2.93M
Debt Repayment	9.98M	-51K	9.95M	16.5M	-15.35M	16.04M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-1.38M	-3.52M	-8.95M	-17.15M	269K	-6.91M
Financial Cash Flow	16.42M	52.05M	29.13M	58.88M	1.26M	81.13M
Net Cash Flow	-7.26M	-39K	-16.8M	10.38M	-29.51M	56.84M
Free Cash Flow	-23.67M	-51.88M	-45.93M	-48.51M	-30.77M	-23.54M
Adj. Free Cash Flow	-27.81M	-58.52M	-51.31M	-54.47M	-35.71M	-27.25M
Maintenance CapEx	n/a	n/a	-20.75M	-3.53M	-1.88M	-625.99K
Growth CapEx	-403K	-3.23M	-2.31M	n/a	-670.37K	-1.55M
Owner Earnings	-23.27M	-48.65M	-43.62M	-48.51M	-30.1M	-21.99M